Merck KGaA's subsidiary MilliporeSigma has developed a first-of-its-kind “all-in-one” CHO genetic stability assay, according to an April 16 release. The company claims that the platform, called ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature ...
Enzyme-powered nanochannels are bringing lab-level precision to handheld biosensors, offering a new way to detect biomarkers with remarkable sensitivity using miniature, biomimicking technology. Image ...
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra ™ CHO genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback